SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Provention Bio Q1 EPS $0.260 Beats $(0.250) Estimate

Provention Bio (NASDAQ:PRVB) reported quarterly earnings of $0.260 per share which beat the analyst consensus estimate of $(0.250) by 204 percent. This is a 189.66 percent increase over losses of $(0.290) per share from

Benzinga · 05/07/2020 20:39

Provention Bio (NASDAQ:PRVB) reported quarterly earnings of $0.260 per share which beat the analyst consensus estimate of $(0.250) by 204 percent. This is a 189.66 percent increase over losses of $(0.290) per share from the same period last year.